Question · Q3 2026
Sato from JPMorgan Chase & Co. inquired about the details of ORIX USA's (OCU) performance, specifically the sale of ORIX Capital Partners (OCP) and its impact on valuation gains. He also asked about the integration of Hilco Global, the revised business plan, and the earnings outlook for OCU, including whether the valuation gain from the recently closed deal was already incorporated.
Answer
Kazuki Yamamoto, Operating Officer, explained that the OCP valuation gain primarily stemmed from significant EBITDA growth of portfolio investees, with consideration for earlier exits from other closed deals. Regarding Hilco Global, a 100-day integration plan is underway to leverage collaboration across the ORIX Group. He confirmed that the valuation gain for the closed deal was already incorporated in the current period, so no additional gains on sales are expected in the next quarter. The overall OCU business plan, including Hilco Global, is being rebuilt and will be detailed in the next earnings call.
Ask follow-up questions
Fintool can predict
IX's earnings beat/miss a week before the call


